Second-generation antipsychotic medications and metabolic disturbance in children and adolescents

Table 4 Correlation between SGA treatment duration and metabolic syndrome indices

Indices	r	CI	P
BMI	0.42	0.21 to 0.59	0.0003*
WC	0.42	0.22 to 0.59	0.0002*
Cholesterol	0.52	0.35 to 0.68	< 0.0001*
LDL	0.53	0.34 to 0.68	< 0.0001*
HDL	− 0.69	− 0.79, − 0.55	< 0.0001*
TG	0.32	0.15 to 0.55	0.002*
FBS	− 0.19	− 0.40 to 0.04	0.11
SBP	− 0.03	− 0.26 to 0.19	0.77
DBP	0.04	− 0.19 to 0.27	0.75
MtS score	0.43	0.22 to 0.60	0.0002*

*Significance P < 0.05
CTL control, SGA second generation treated patients, r correlation, CL confidence interval, P value, BMI body mass index, WC waist circumference, LDL low density lipoprotein, HDL high density lipoprotein, TG triglycerides, FBS fasting blood sugar, MtS score metabolic syndrome score